Inzidenz und Langzeitprognose des papillären Nierenzellkarzinoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inzidenz und Langzeitprognose des papillären Nierenzellkarzinoms

Published:2011-08-17 Issue:9 Volume:50 Page:1125-1129
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Waalkes S., ,Roos F.C.,Eggers H.,Schumacher S.,Janssen M.,Wegener G.,Thüroff J.W.,Hofmann R.,Schrader M.,Kuczyk M.A.,Schrader A.J.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-011-2684-6.pdf

Reference29 articles.

1. Schrader AJ, Varga Z, Hegele A et al (2006) Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol 132:137–149

2. Motzer RJ, Bacik J, Mariani T et al (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20:2376–2381

3. Herrmann E, Brinkmann OA, Bode ME et al (2007) Treatment of metastatic papillary renal cell carcinoma with immunochemotherapy with interleukin-2, interferon-alpha and 5- fluorouracil. J Clin Oncol 25:15644

4. Schmidt L, Duh FM, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68–73

5. Sweeney P, El-Naggar AK, Lin SH, Pisters LL (2002) Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol 168:51–55

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and clinicopathological characteristics of renal cell carcinoma: does bilateral occurrence influence overall and cancer-specific survival?;Translational Cancer Research;2020-02

2. Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles;BioMed Research International;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3